Advanced search×

The classical drug discovery approach to defining bioactive constituents of botanicals

Fitoterapia 82(1):9 (2011) PMID 20804827

In this review, several recently identified biologically active principles of selected botanical dietary supplement ingredients are described, and were isolated using classical phytochemical chromatographic methods, with various spectroscopic procedures used for their isolation and structure elucidation. A central component of such an approach is ''activity-guided fractionation'' to monitor the compound purification process. In vitro assays germane to cancer chemoprevention were used to facilitate the work performed. Bioactive compounds, including several new substances, were characterized from acai (Euterpe oleracea), baobab (Adansonia digitata), licorice (Glycyrrhiza glabra), mangosteen (Garcinia mangostana), and noni (Morinda citrifolia). Many of these compounds exhibited quite potent biological activity, but tended to be present in their plant of origin only at low concentration levels.

DOI: 10.1016/j.fitote.2010.08.015
Version: za2963e q8za7 q8zb8 q8zc7 q8zdf q8ze5 q8zff q8zgc

Similar articles you may find interesting…

  1. Inhibition of chemiluminescence and chemotactic activity of phagocytes in vitro by the extracts of selected medicinal plants.

    J Nat Med 65(2):400-5 (2011) PMID 21184195

    We also tested the effect of the extracts on chemotactic migration of PMNs using the Boyden chamber technique. The extracts of Curcuma domestica L., Phyllanthus amarus Schum & Thonn and C. xanthorrhiza Roxb. were the samples producing the strongest oxidative burst of PMNs with luminol-based chemilum...
  2. An Efficient And Versatile Synthesis Of Glcnacstatins - Potent And Selective O-Glcnacase Inhibitors Built On The Tetrahydroimidazo[1,2-A]Pyr...

    Tetrahedron 66(39-3):12 (2010) PMID 20976183

    We report a novel approach to the synthesis of GlcNAcstatins-members of an emerging family of potent and selective inhibitors of peptidyl O-GlcNAc hydrolase build upon tetrahydroimidazo[1,2-a]pyridine scaffold. Making use of a streamlined synthetic sequence featuring de novo synthesis of imidazoles...
  3. Natural compounds with aromatase inhibitory activity: an update.

    Planta Med 76(11):1087-93 (2010) PMID 20635310

    Several synthetic aromatase inhibitors are currently in clinical use for the treatment of postmenopausal women with hormone-receptor positive breast cancer. However, these treatments may lead to untoward side effects and so the search for new aromatase inhibitors continues, especially those for whic...